CHI3L1 and metabolic dysfunction-associated steatotic liver disease: Although previous RNA sequencing data from the Illumina Human Body Map 2.0 (http://genomicdbdemo.bxgenomics.com) showed that the Chi3L1 gene was highly expressed in human liver [22], it remained unknown if Chi3L1 is expressed in human hepatocytes in the context of developing a NAFLD/NASH phenotype.